HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunohistochemical studies of PIVKA-II in hepatocellular carcinoma by indirect immunofluorescence.

Abstract
Tissue PIVKA-II was examined in 32 hepatocellular carcinomas and 2 metastatic liver tumors using indirect immunofluorescence, and the results were compared with the size, histological grading and serum PIVKA-II level. The specificity of this method was confirmed by the disappearance of reactivity in PLC/PRF/5 cells after the addition of vitamin K to the culture medium. Positive PIVKA-II staining was observed as a clustered or a single cell pattern only in the HCC nodules, but not in the surrounding cirrhotic tissue. PIVKA-II staining was observed in all HCC groups regardless of histological grade. There was no relationship between PIVKA-II staining and the size of HCC. PIVKA-II was detected immunohistochemically even in small HCC of patients whose plasma PIVKA-II levels were below the detection limit. These results suggest that PIVKA-II production is a specific phenotype of HCC regardless of its histological grading and demonstrate that this immunofluorescent PIVKA-II staining is more sensitive and useful than plasma PIVKA-II assay for the diagnosis of HCC.
AuthorsN Kuwahara, T Higashi, K Nouso, T Ito, T Tsuji
JournalActa medica Okayama (Acta Med Okayama) Vol. 49 Issue 1 Pg. 19-24 (Feb 1995) ISSN: 0386-300X [Print] Japan
PMID7762405 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Biomarkers, Tumor
  • Protein Precursors
  • acarboxyprothrombin
  • Prothrombin
Topics
  • Biomarkers
  • Biomarkers, Tumor (analysis, blood)
  • Carcinoma, Hepatocellular (blood, chemistry, pathology)
  • Fluorescent Antibody Technique
  • Humans
  • Immunohistochemistry
  • Liver Neoplasms (blood, chemistry, pathology)
  • Neoplasm Staging
  • Protein Precursors (analysis)
  • Prothrombin (analysis)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: